149 related articles for article (PubMed ID: 12871312)
1. Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist.
Lenain N; Freund M; Léon C; Cazenave JP; Gachet C
J Thromb Haemost; 2003 Jun; 1(6):1144-9. PubMed ID: 12871312
[TBL] [Abstract][Full Text] [Related]
2. Platelet ADP receptors contribute to the initiation of intravascular coagulation.
Leon C; Alex M; Klocke A; Morgenstern E; Moosbauer C; Eckly A; Spannagl M; Gachet C; Engelmann B
Blood; 2004 Jan; 103(2):594-600. PubMed ID: 12969982
[TBL] [Abstract][Full Text] [Related]
3. Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.
Léon C; Freund M; Ravanat C; Baurand A; Cazenave JP; Gachet C
Circulation; 2001 Feb; 103(5):718-23. PubMed ID: 11156884
[TBL] [Abstract][Full Text] [Related]
4. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S
Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350
[TBL] [Abstract][Full Text] [Related]
5. The platelet P2 receptors in arterial thrombosis.
Gachet C; Léon C; Hechler B
Blood Cells Mol Dis; 2006; 36(2):223-7. PubMed ID: 16466948
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Savi P; Herbert JM
Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
[TBL] [Abstract][Full Text] [Related]
7. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
8. Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice.
Hechler B; Zhang Y; Eckly A; Cazenave JP; Gachet C; Ravid K
J Thromb Haemost; 2003 Jan; 1(1):155-63. PubMed ID: 12871553
[TBL] [Abstract][Full Text] [Related]
9. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
10. Can the PFA-100 be modified to detect P2Y12 inhibition?
Pidcock M; Harrison P
J Thromb Haemost; 2006 Jun; 4(6):1424-6. PubMed ID: 16706997
[No Abstract] [Full Text] [Related]
11. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
Baurand A; Raboisson P; Freund M; Léon C; Cazenave JP; Bourguignon JJ; Gachet C
Eur J Pharmacol; 2001 Feb; 412(3):213-21. PubMed ID: 11166284
[TBL] [Abstract][Full Text] [Related]
12. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
[TBL] [Abstract][Full Text] [Related]
13. Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel.
Labarthe B; Babin J; Bryckaert M; Théroux P; Bonnefoy A
Br J Pharmacol; 2012 May; 166(1):221-31. PubMed ID: 21950486
[TBL] [Abstract][Full Text] [Related]
14. The ADP receptor P2Y(1) mediates t-PA release in pigs during cardiac ischemia.
Olivecrona GK; Götberg M; Harnek J; Jacobson KA; Jern S; Erlinge D
J Thromb Thrombolysis; 2007 Oct; 24(2):115-22. PubMed ID: 17294140
[TBL] [Abstract][Full Text] [Related]
15. The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented.
Mangin P; Ohlmann P; Eckly A; Cazenave JP; Lanza F; Gachet C
J Thromb Haemost; 2004 Jun; 2(6):969-77. PubMed ID: 15140133
[TBL] [Abstract][Full Text] [Related]
16. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
17. Identification, characterization, and inhibition of the platelet ADP receptors.
Gachet C
Int J Hematol; 2001 Dec; 74(4):375-81. PubMed ID: 11794691
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel, independent of the vascular P2Y12 receptor, improves arterial function in small mesenteric arteries from AngII-hypertensive rats.
Giachini FR; Osmond DA; Zhang S; Carneiro FS; Lima VV; Inscho EW; Webb RC; Tostes RC
Clin Sci (Lond); 2010 Apr; 118(7):463-71. PubMed ID: 19811450
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity.
Niitsu Y; Jakubowski JA; Sugidachi A; Asai F
Semin Thromb Hemost; 2005 Apr; 31(2):184-94. PubMed ID: 15852222
[TBL] [Abstract][Full Text] [Related]
20. The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation.
Nylander S; Mattsson C; Ramström S; Lindahl TL
Thromb Res; 2003; 111(1-2):65-73. PubMed ID: 14644082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
